`571-272-7822
`
`
`Paper No. 43
`
`Entered: January 23, 2019
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`FISHER & PAYKEL HEALTHCARE LIMITED,
`Petitioner,
`
`v.
`
`RESMED LIMITED,
`Patent Owner.
`____________
`
`Case
`IPR2017-00632
` Patent 8,944,061 B2
`____________
`
`
`Before BARRY L. GROSSMAN, BEVERLY M. BUNTING, and
`JAMES J. MAYBERRY, Administrative Patent Judges.
`
`BUNTING, Administrative Patent Judge.
`
`
`
`
`
`
`
`FINAL WRITTEN DECISION
`35 U.S.C. § 318(a) and 37 C.F.R. § 42.73
`
`
`
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`
`I. INTRODUCTION
`Fisher & Paykel Healthcare Limited (“Petitioner”) filed a Petition
`(Paper 1, “Pet.”) requesting an inter partes review of claims 17, 18, 20–23,
`26–30, 32, 33, 35–38, 41–46, and 48–91 (“the challenged claims”) of U.S.
`Patent No. 8,944,061 B2 (Ex. 1001, “the ’061 patent”). ResMed Ltd.
`(“Patent Owner”) filed a preliminary response to the Petition. Paper 7
`(“Prelim. Resp.”). On July 25, 2017, we entered a Decision on Institution
`(Paper 8, “Decision” or “Dec.”), determining that Petitioner had presented
`sufficient arguments and evidence demonstrating a reasonable likelihood
`that it would prevail in showing claims 17, 18, 20, 21, 23, 28–30, 32, 33, 35,
`36, 38, 43–46, 81, 84, 85, 87, and 88 of the ’061 patent would be
`unpatentable, but not claims 22, 26, 27, 37, 41, 42, 48–80, 82, 83, 86, 89–91.
`Petitioner timely filed a Request for Rehearing (Paper 10), which we denied
`(Paper 26).
`Subsequent to institution, Patent Owner filed a Patent Owner
`Response (Paper 14, “PO Resp.”), and Petitioner filed a Reply (Paper 16,
`“Reply”).1 Pursuant to the U.S. Supreme Court’s decision on April 24,
`2018, in SAS Inst., Inc. v. Iancu, 138 S. Ct. 1348 (2018), we modified our
`Decision on Institution on May 3, 2018, to include the challenge to claims
`22, 26, 27, 37, 41, 42, 48–80, 82, 83, 86, and 89–91.2 Paper 29 (modifying
`the Decision on Institution to include all claims and all grounds presented in
`the Petition). Based on the parties’ requests for additional briefing to
`
`
`1 Patent Owner filed a Motion for Observations (Paper 34), and Petitioner
`filed a Response (Paper 38).
`2 In our Decision Denying Petitioner’s Request for Hearing, we recognized
`that the Decision on Institution erroneously listed claim 91 as an instituted
`claim. (Paper 26).
`
`
`
`2
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`address the newly-added challenges, we determined that good cause existed
`to permit additional briefing addressing the newly added challenges. Paper
`31. Patent Owner submitted a Supplemental Response (Paper 32, “Supp.
`Resp.”) and Petitioner filed a Supplemental Reply (Paper 33, “Supp.
`Reply”). Oral argument was held on July 11, 2018, and a transcript has been
`entered into the record. 3 Paper 42 (“Tr.”). Although the one-year period
`normally available to issue a Final Written Decision was to expire on July
`25, 2018, the Chief Judge determined that good cause existed to extend this
`deadline by up to six months. Papers 40–41.
`This Final Written Decision is entered pursuant to 35 U.S.C. § 318(a).
`For the reasons that follow, we conclude that Petitioner has demonstrated, by
`a preponderance of the evidence, that certain of the challenged claims
`identified in the Order, i.e., Section V., are unpatentable.
`
`II. BACKGROUND
`A. Real Party in Interest
`Petitioner identifies Fisher & Paykel Healthcare Limited as the real
`party in interest. Pet. 11.
`
`B. Related Matters
`The parties indicate that the ʼ061 patent has been asserted in: Fisher &
`Paykel Healthcare Ltd. v. ResMed Corp., No. 3:16-cv-02068-DMS-WVG
`(S.D. Cal.). Pet. 11; Paper 4, 2. Petitioner concurrently filed two other
`petitions challenging the ’061 patent, IPR2017-00634 and IPR2017-00635,
`both of which were denied. Pet. 11; Paper 4, 2.
`
`
`3 Oral argument was rescheduled at the request of the parties to provide time
`for additional briefing directed to the newly instituted claims. Paper 28.
`
`
`
`3
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`
`C. The ʼ061 Patent (Ex. 1001)
`The ’061 patent, titled “Cushion to Frame Assembly Mechanism,”
`issued on February 3, 2015, and claims priority from an application filed on
`January 12, 2006, and two provisional applications filed on October 14 and
`November 9, 2005, respectively. Ex. 1001, (45), (54), (60), (63). The ’061
`patent relates to a patient interface for use in treatment of sleep disordered
`breathing, such as obstructive sleep apnea, and, in particular, to an apparatus
`for securing a face-contacting portion of a patient interface, such as a
`cushion, to a frame or shell of the patient interface. Id. at 1:17–23.
`The patient interface includes mask assembly 210, as illustrated in
`Figure 3, and is reproduced below. Ex. 1001, 6:53–58.
`
`
`
`4
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`
`
`Figure 3 is an exploded view of the mask assembly.
`Mask assembly 210 includes skeleton frame 212, which is adapted to
`interlock removably with cushion/frame sub-assembly 230. Id. at 6:56–58.
`Cushion/frame sub-assembly 230 incorporates an integrally molded one-
`piece frame and cushion. Id. at 6:59–60. Cushion/frame sub-assembly 230
`includes upper wall 220, having opening 218 surrounded by annular wall
`240, for communicating with an inlet conduit. Id. at 6:64–67. Skeleton
`frame 212 further includes upper support member 244, adapted to support a
`forehead support, lower headgear clip receptacles 246 that engage a
`
`
`
`5
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`headgear assembly, and annular connection seal 238 adapted to engage an
`inlet conduit. Id. at 7:11–17.
`Figure 4, reproduced below, illustrates engagement of skeleton frame
`212 with cushion/frame sub-assembly 230. Ex. 1001, 7:22–23.
`
`
`Figure 4 is a perspective view of the assembled mask assembly.
`Skeleton frame 212 engages with cushion/frame sub-assembly 230 by
`interlocking annular elbow connection seal 248 with annular wall 240,
`interlocking or frictionally engaging upper support member 244 with top
`portion 231 of cushion/frame sub-assembly 230, and interlocking elongated
`frame members 250 with corresponding protrusions on cushion/frame sub-
`assembly 230. Ex. 1001, 7:22–30.
`
`D. Challenged Claims
`Of the challenged claims, claims 17, 32, 51, 58, 65, 74, and 81 are
`independent. Ex. 1001, 20:58–28:34. Each of the independent claims
`
`
`
`6
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`recites, inter alia, a “first frame” or “frame,” a cushion, and a “second
`frame” or “skeleton frame.” Claims 51, 65, and 81 are illustrative of the
`claimed subject matter, and are reproduced below:
`51. A mask assembly for treatment of sleep disorder breathing
`by delivering a flow of pressurized gas to a patient, the mask
`assembly comprising:
`a first frame with a first opening adapted to fluidly
`communicate an interior of the first frame with an inlet
`conduit, the first frame being made of a first material;
`a cushion with a side wall and a face contacting portion
`extending from the side wall, wherein the cushion is over-
`molded to the first frame to form a cushion/frame sub-
`assembly and the cushion is adapted to form a seal around
`a patient’s nose and mouth, the cushion being made of a
`second material that is less rigid than the first material; and
`a second frame adapted to removably interlock with the
`cushion/frame sub-assembly, the second frame including
`an upper member configured to provide forehead support;
`lower portion with a second opening aligned with the first
`opening so that the inlet conduit fluidly communicates
`with a breathing chamber formed by the cushion and
`the first frame, and with headgear attachment structures
`on opposed lateral sides of the second opening, the
`headgear attachment structures being adapted to
`engage with headgear attachments;
`two elongate frame members that interconnect the upper
`member and lower portion; and
`an open space bounded at least in part by the two elongate
`frame members and the lower portion;
`wherein the first frame protrudes at least partially through the
`open space.
`Id. at 24:1–31.
`65. A mask assembly for treatment of sleep disorder breathing
`by delivering a flow of pressurized gas to a patient, the mask
`assembly comprising:
`a cushion adapted to form a seal by abutting a patient’s face
`around the patient’s nose and mouth, the cushion
`
`
`
`7
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`comprising a face contacting portion with a sealing portion
`that contacts the patient’s face around the patient’s nose
`and mouth and comprising a first material;
`a frame integrally molded to the cushion, the frame
`comprising an annular wall surrounding an opening that is
`adapted to allow fluid communication of the pressurized
`gas to an interior of the frame and a second wall
`surrounding the annular wall and connected to the cushion
`and comprising a second material that is more rigid than
`the first material;
`an inlet conduit in fluid communication with the frame to
`communicate the pressurized gas to the interior of the
`frame; and
`a skeleton frame adapted to be removably engageable with
`the frame, the skeleton frame comprising an upper support
`member adapted to receive a forehead contacting portion,
`a lower frame member comprising attachment locations
`adapted to engage with clips for straps, two frame
`members interconnecting the upper support member and
`the lower frame member and forming an open space
`between the two frame members and the lower frame
`member, wherein
`the skeleton frame and the frame are adapted to be releasably
`engageable to one another at the opening, and
`the frame is at least partially accessible through the open
`space.
`Id. at 25:37–67.
`81. A mask assembly for treatment of sleep disorder breathing
`by delivering a flow of pressurized gas to a patient, the mask
`assembly comprising:
`a first frame made of first material;
`a cushion connected to the first frame, the cushion being
`adapted to form a seal around the patient’s nose and mouth
`and being made from a second material that is more
`flexible than the first material, the first frame and the
`cushion together forming a breathing chamber; and
`a second frame adapted to constrain the first frame, the second
`frame comprising an upper member, a lower member with
`an annular opening adapted to allow an inlet conduit to
`
`
`
`8
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`provide pressurized gas to the patient, and a separate
`opening located between the annular opening and the
`upper member, the separate opening providing access to
`the first frame when the mask assembly is fully assembled,
`wherein the first frame and the second frame snap-fit together.
`Id. at 27:13–31.
`
`E. Grounds of Unpatentability
`Petitioner challenges claims 17, 18, 20–23, 26–30, 32, 33, 35–38, 41–
`46, and 48–91 of the ’061 patent on the following grounds (Pet. 15):
`
` References
`Berthon-Jones4 and
`Barnett5
`Berthon-Jones, Barnett,
`and Lithgow6
`Berthon-Jones, Barnett,
`Lithgow, and Burns7
`
` Basis
`§ 103(a)
`
`§ 103(a)
`
`§ 103(a)
`
`Claims Challenged
`81–91
`17, 18, 20–23, 26–30, 32,
`33, 35–38, 41–46, 48–50,
`and 58–73
`51–57 and 74–80
`
`
`
`In support of its arguments, Petitioner relies on the declaration of
`Jason Eaton, P.E. (Ex. 1006) and Patent Owner relies on the declaration of
`Mr. Alexander Virr (Ex. 2003). The parties rely on other exhibits as
`discussed below.
`
`III. ANALYSIS
`A. Legal Principles
`1. Burden of Proving Unpatentability
`In an inter partes review, the petitioner bears the burden of proving
`unpatentability of the challenged claims, and the burden of persuasion never
`
`
`4 WO 2004/041342 A1, pub. May 21, 2004 (Ex. 1002, “Berthon-Jones”).
`5 US 6,412,488 B1, iss. July 2, 2002 (Ex. 1003, “Barnett”).
`6 US 2004/0118406 A1, pub. June 24, 2004 (Ex. 1004, “Lithgow”).
`7 US 5,062,421, iss. Nov. 5, 1991 (Ex. 1005, “Burns”).
`
`
`
`9
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`shifts to the patent owner. Dynamic Drinkware, LLC v. Nat’l Graphics, Inc.,
`800 F.3d 1375, 1378 (Fed. Cir. 2015). To prevail in this proceeding,
`Petitioner must support its challenges by a preponderance of the evidence.
`35 U.S.C. § 316(e); 37 C.F.R. § 42.1(d). Accordingly, all of our findings
`and conclusions are based on a preponderance of the evidence.
`
`2. Obviousness
`A claim is unpatentable under § 103(a) if the differences between the
`claimed subject matter and the prior art are such that the subject matter, as a
`whole, would have been obvious at the time the invention was made to a
`person having ordinary skill in the art to which said subject matter pertains.
`KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 406 (2007). The question of
`obviousness is resolved on the basis of underlying factual determinations,
`including: (1) the scope and content of the prior art; (2) any differences
`between the claimed subject matter and the prior art; (3) the level of skill in
`the art; and (4) where in evidence, so-called secondary considerations.
`Graham v. John Deere Co., 383 U.S. 1, 17–18 (1966). The U.S. Court of
`Appeals for the Federal Circuit has made clear that a petitioner in an inter
`partes review proceeding cannot “satisfy its burden of proving obviousness”
`by “employ[ing] mere conclusory statements” and “must instead articulate
`specific reasoning, based on evidence of record” to support an obviousness
`determination. In re Magnum Oil Tools Int’l, 829 F.3d 1364, 1380–81 (Fed.
`Cir. 2016).
`We analyze the following grounds of unpatentability in accordance
`with the above-stated principles. Because Patent Owner does not provide
`evidence regarding secondary considerations, our determination is based on
`the first three factors. See PO Resp.; Pet. 106; see also ZUP, LLC v. Nash
`Mfg., Inc., 896 F.3d 1365, 1373 (Fed. Cir. 2018) (“While [the] burden of
`
`
`
`10
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`persuasion remains with the challenger, a patentee bears the burden of
`production with respect to evidence of secondary considerations of
`nonobviousness.”).
`
`B. Level of Skill in the Art
`In determining the level of ordinary skill in the art, various factors
`may be considered, including the “type of problems encountered in the art;
`prior art solutions to those problems; rapidity with which innovations are
`made; sophistication of the technology; and educational level of active
`workers in the field.” In re GPAC, Inc., 57 F.3d 1573, 1579 (Fed. Cir. 1995)
`(citation omitted). In that regard, Petitioner asserts that a person having
`ordinary skill in the art (“POSITA”) “would have at least a bachelor’s
`degree in mechanical engineering, biomedical engineering or other similar
`type of engineering degree combined with at least two years of experience in
`the field of masks, respiratory therapy, patient interfaces or relevant product
`design experience.” Pet. 21 (citing Ex. 1006 ¶ 26). Patent Owner does not
`expressly state its position on the level of ordinary skill in the art in its
`Patent Owner Response. See generally PO Resp. Mr. Virr, Patent Owner’s
`expert, generally accepts Petitioner’s framework. See e.g., Ex. 2003 ¶ 25
`(“My analysis is thus based on the perspective of a POSITA having this
`level of knowledge and skill.”).
`Thus, based on the entire record, we accept Petitioner’s formulation,
`finding that the POSITA “would have at least a bachelor’s degree in
`mechanical engineering, biomedical engineering or other similar type of
`engineering degree combined with at least two years of experience in the
`field of masks, respiratory therapy, patient interfaces or relevant product
`design experience.” Ex. 1006 ¶ 26.
`
`
`
`11
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`
`C. Claim Construction
` The Board interprets claims of an unexpired patent using the broadest
`reasonable construction in light of the specification of the patent in which
`they appear. 8 37 C.F.R. § 42.100(b); Cuozzo Speed Techs., LLC v. Lee,
`136 S. Ct. 2131, 2144–46 (2016). Under the broadest reasonable
`interpretation standard, and absent any special definitions, claims terms are
`given their ordinary and customary meaning, as would be understood by one
`of ordinary skill in the art in the context of the entire disclosure. In re
`Translogic Tech. Inc., 504 F.3d 1249, 1257 (Fed. Cir. 2007). Any special
`definitions for claim terms or phrases must be set forth with reasonable
`clarity, deliberateness, and precision. In re Paulsen, 30 F.3d 1475, 1480
`(Fed. Cir. 1994). In the absence of such a definition, limitations are not to
`be read from the specification into the claims. See In re Van Geuns,
`988 F.2d 1181, 1184 (Fed. Cir. 1993).
`Petitioner does not propose a specific construction for any claim term
`in its Petition, applying the “broadest reasonable interpretation in light of the
`specification of the ’061 patent.” Pet. 16. Patent Owner agrees. PO Resp.
`17–18. In our Decision on Institution, we determined that no express
`construction of any claim term was necessary. Dec. 9–10 (citing Vivid
`Techs., Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d 795, 803 (Fed. Cir. 1999).
`Now, having considered the entire record, we conclude that our
`determination regarding the obviousness of the challenged claims does not
`turn on the interpretation of any of the claim terms, and that no express
`
`
`8 The USPTO revised its rules to harmonize the Board’s claim construction
`standard with that used in federal district court. 83 Fed. Reg. 51,340 (Nov.
`13, 2018). This rule change applies to petitions filed after November 13,
`2018, however, and does not apply to this proceeding. Id.
`
`
`
`12
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`construction of any claim term is necessary for purposes of this Final
`Written Decision.
`
`D. Obviousness Based on Berthon-Jones and Barnett
`Petitioner challenges the patentability of claims 81–91 of the ’061
`patent under 35 U.S.C. § 103 as obvious based on Berthon-Jones and
`Barnett. In support thereof, Petitioner identifies the disclosures in the cited
`references alleged to describe the subject matter in the challenged claims, as
`well as a reason why a POSITA would have modified Berthon-Jones based
`on the teachings of Barnett. Id. at 23–56. Petitioner supports its arguments
`and evidence with the testimony of its declarant, Mr. Eaton. Ex. 1006.
`Patent Owner disputes that Berthon-Jones teaches certain limitations
`in claims 81–91, and further argues that the proposed combination of
`Berthon-Jones and Barnett is unavailing for the reasons discussed infra. PO
`Resp. 18–49. Patent Owner supports its arguments and evidence with the
`testimony of its declarant, Mr. Virr. Ex. 2003.
`For the reasons that follow, we conclude that Petitioner has
`established by a preponderance of the evidence that claims 81, 84, 85, 87,
`and 88 are unpatentable, but not claims 82, 83, 86, and 89–91. We begin our
`analysis with a brief summary of the cited references and then address the
`parties’ contentions in turn.
`1. Berthon-Jones (Ex. 1002)
`Berthon-Jones is a PCT publication titled “Mask and Components
`Therof” having an international publication date of May 21, 2004. Ex. 1002
`(43), (54). Berthon-Jones relates to a “comfortable low-leak mask assembly
`for use with Non-Invasive Positive Pressure Ventilation (NIPPV).” Id.
`¶ (57). Figure 51 of Berthon-Jones, reproduced below, is representative.
`
`
`
`13
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`
`
`Figure 51 is an exploded perspective view of mask assembly 510.
`Mask assembly 510 includes semi-rigid chassis 512 that connects to
`headgear, and cushion/secondary frame 514 adapted to form a seal with the
`user’s face. Id. ¶ 177. Cushion/secondary frame 514 includes fixedly
`connected cushion portion 516 and secondary frame portion 518. Id. ¶ 179.
`“[S]econdary frame portion 518 maybe be made of a flexible or semi-
`flexible material, e.g., polypropylene.” Id. ¶ 180. Cushion portion 516 is “a
`generally soft and conforming structure.” Id. ¶ 181. Cushion/secondary
`frame 514 includes connecting members 524, which interface with receiving
`holes 526 in chassis 512 to provide a snap-fit connection between
`cushion/secondary frame 514 and chassis 512. Id. ¶ 182.
`Mask chassis 512 includes central aperture 536 adapted to receive
`raised, central portion 518 of cushion/secondary frame 514, to provide a
`conduit for gas delivery through central aperture 536. Id. ¶ 184. Adjustment
`wheel retaining portions 542 are positioned adjacent each side of central
`aperture 536, and correspond to projections 528 on cushion/secondary frame
`
`
`
`14
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`514. Id. The user turns adjustment wheels 530 to modify the sealing force
`and/or fit between the user and cushion portion 516. Id. ¶ 186.
`2. Barnett (Ex. 1003)
`Barnett is a U.S. Patent titled “Low-Contact Nasal Mask and System
`Using Same” having an issue date of July 2, 2002. Ex. 1003, (54), (45).
`Barnett is directed to a low contact nasal mask having “a one-piece, light
`weight seal member defining a nose receiving cavity, a collar coupled to the
`seal member, and a conduit coupling member, and to a system for supplying
`a flow of gas to a patient that incorporates such a low contact nasal mask.”
`Ex. 1003, 1:9–13. As shown in Figure 1a, reproduced below, nasal mask
`assembly 30 includes collar 34 and conduit coupling member 36. Id. at
`3:48–50.
`
`
`Figure 1a is a sectional side view of the nasal mask assembly.
`Conduit coupling member 36 is rotatably mounted to collar 34 “so that
`conduit coupling member 36 freely rotates over a range of 360° about a
`center axis of collar 34.” Id. at 3:53–56.
`3. Discussion
`a. Petitioner’s Challenge to Claim 81
`i. Undisputed Limitations of Claim 81
`
`
`
`15
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`Claim 81 is independent. Petitioner relies on the disclosure in
`Berthon-Jones for most of the limitations of claim 81, and Barnett for the
`rest. Pet. 27–46. Petitioner annotated Figure 51 of Berthon-Jones,
`reproduced below, to illustrate the purported correspondence between
`Berthon-Jones and claim 81. Id. at 28.
`
`
`Figure 51 of Berthon-Jones shows an exploded view of mask
`assembly 510, as annotated by Petitioner.
`For example, the preamble of claim 81 is directed to “[a] mask
`assembly for treatment of sleep disorder breathing by delivering a flow of
`pressurized gas to a patient” (Ex. 1001, 27:13–14), and Petitioner contends
`that Berthon-Jones’ mask assembly 510 likewise delivers pressurized gas to
`a patient to treat sleep disordered breathing (Pet. 30). Claim 81 also requires
`“a first frame made of a first material.” Ex. 1001, 27:16. Petitioner
`contends that this limitation is satisfied by the teaching in Berthon-Jones that
`first frame 518 “may be made of a flexible or semi-flexible material, e.g.,
`polypropylene.” Pet. 31 (citing Ex. 1002 ¶ 180).
`
`
`
`16
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`Claim 81 also requires “a cushion connected to the first frame, the
`cushion being adapted to form a seal around a patient’s nose and mouth and
`being made from a second material that is more flexible than the first
`material, the first frame and the cushion together forming a breathing
`chamber.” Ex. 1001, 27:17–21. Petitioner contends that this claim element
`is satisfied by the disclosure in Berthon-Jones of cushion 516, which is made
`of a soft material that is more flexible that the semi-soft material of first
`frame 518, and that when connected, cushion 516 and first frame 518 form a
`breathing chamber. Pet. 32–33 (citing Ex. 1002 ¶ 179–181; Ex. 1006 ¶¶ 55–
`57).
`
`Claim 81 additionally recites that “the first frame and second frame
`snap-fit together.” Ex. 1001, 27:31–32. Petitioner asserts that the disclosure
`in Berthon-Jones regarding the snap-fit engagement of connecting members
`524 on the secondary frame portion into corresponding receiving holes 526
`in the mask chassis satisfies this claim limitation. Pet. 46 (citing Ex. 1002
`¶ 182).
`Patent Owner does not dispute Petitioner’s contentions with regards to
`these undisputed claim limitations of claim 81. See PO Resp.9 Now, in
`view of the entire record, we adopt as our own Petitioner’s analysis of the
`
`
`9 The scheduling order in this proceeding reminded Patent Owner that
`“any arguments for patentability not raised in the [Patent Owner
`Response] will be deemed waived.” Paper 9, 3; see also In re
`Nuvasive, Inc., 842 F.3d 1376, 1380–81 (Fed. Cir. 2016) (holding that a
`patentee waived an argument by presenting it only in the preliminary
`proceeding and not during the trial, despite the Board cautioning the
`patentee that arguments not briefed in the response would be deemed
`waived).
`
`
`
`17
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`undisputed claim limitations as recited in independent claim 81, and find
`that Berthon-Jones teaches these limitations.
`ii. Annular Opening Limitation
`We turn next to the disputed limitations of claim 81. Claims 81 also
`recites a second frame that constrains the first frame, and includes “an upper
`member, [and] a lower member with an annular opening adapted to allow an
`inlet conduit to provide pressurized gas to the patient.” Ex. 1001, 27:22–25.
`Petitioner contends that Berthon-Jones teaches second frame 512 as having
`upper member 540 and opening 536 that receives and constrains the raised
`portion of first frame 518. Pet. 34 (citing Ex. 1002 ¶¶ 177, 183–184).
`Petitioner explains that opening 536 in the lower portion of second frame
`512 provides an inlet conduit to provide pressurized gas to the patient, but
`recognizes that Berthon-Jones does not expressly disclose that opening 536
`is annular. Id. at 35 (citing Ex. 1002 ¶ 184; Ex. 1006 ¶¶ 59–70). Relying on
`the testimony of Mr. Eaton, Petitioner contends that “configuring the second
`frame 512 to directly support the inlet conduit (elbow) at an annular opening
`that allows pressurized gas to pass from the elbow to the patient was well-
`known and common in the prior art.” Id. (citing Ex. 1006 ¶¶ 59–70).
`Petitioner relies on Barnett’s teaching regarding “second frame 34 that
`directly attaches to and supports the inlet conduit 36 at an annular opening
`76,” to illustrate that it was known to utilize a frame having an annular
`opening to receive an inlet conduit. Id. at 36 (citing Ex. 1003, 3:52–57,
`8:66–9:43). Petitioner also contends that it was known to provide an annular
`opening in the second frame for directly attaching the inlet conduit with the
`second frame, as also taught by Barnett. Id. at 39 (citing Ex. 1006 ¶ 67; Ex.
`1003, 3:52–57, Pet. § I). Petitioner annotated Figure 1A of Barnett,
`
`
`
`18
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`reproduced below, to illustrate the alleged correspondence between Barnett
`and claim 81. Id. at 36.
`
`
`
`Figure 1A of Barnett illustrating a side view of
`the mask assembly, as annotated by Petitioner.
`Petitioner argues that a POSITA “would have viewed these two types
`of frame-elbow arrangements as two design choices for establishing a seal
`between an interior of an elbow and a breathing chamber.” Pet. 41 (citing
`Ex. 1006 ¶¶ 61–70). According to Petitioner, “[a] person of skill in the art
`would have selected the Barnett configuration as one of a finite number of
`predictable solutions for providing a connection between the interior of the
`elbow and the breathing chamber.” Id. (citing KSR, 550, U.S. at 421).
`Petitioner contends that the advantages of the proposed Berthon-Jones and
`Barnett arrangement would have motivated a POSITA to modify Berthon-
`Jones in view of Barnett. Id. Namely, because
`Berthon-Jones and Lovell10 utilize a direct connection between
`the elbow and the cushion sub-assembly, which requires only a
`
`10 US 6,631,718 B1, issued Oct. 14, 2003 (Ex. 1012, “Lovell”).
`
`
`
`19
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`single seal, and Barnett and Gunaratnam11 teach separate sealed
`connections between: 1) the second frame and the inlet conduit,
`and 2) the second frame and the cushion-frame sub-assembly.
`[Ex. 1006] ¶¶ 66–68. Although Barnett and Gunaratnam require
`two separate seals, directly attaching the inlet conduit to the
`second frame would make it easier for a patient to detach the
`cushion-frame sub-assembly from the second frame without
`affecting the engagement of the inlet conduit with the second
`frame. Id. ¶¶ 62, 69.
`Id. Petitioner maintains that the proposed modification would enable
`the user to remove the cushion-frame sub-assembly without having to
`disconnect the elbow from the second frame, “making reassembly
`easier for the user.” Id. at 42 (citing Ex. 1006 ¶¶ 62, 69).
`Patent Owner does not dispute Petitioner’s assertion that Barnett
`teaches a second frame that attaches and supports an inlet conduit at an
`annular opening. Instead, Patent Owner advances arguments and evidence
`challenging the reasons offered by Petitioner to combine Berthon-Jones and
`Barnett. For example, Patent Owner argues that Petitioner improperly used
`hindsight in proposing that a POSITA would have modified Berthon-Jones’
`mask to use Barnett’s collar connection. PO Resp. 18–46. We address
`Patent Owner’s arguments regarding the proposed modification of Berthon-
`Jones using the teachings of Barnett below.
`a) Whether Petitioner’s Proposed Modification Is Based On
`Hindsight
`Patent Owner argues that Petitioner’s proposed modification to
`Berthon-Jones, including “(1) modif[ing] Berthon-Jones’s mask chassis to
`incorporate Barnett’s collar structure, (2) further modif[ing] the proposed
`mask chassis/collar structure to include an annular opening that directly
`
`
`11 US 6,796,308 B2, issued Sept. 28, 2004 (Ex. 1014, “Gunaratnam”).
`
`
`
`20
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`engages with Barnett’s elbow inlet conduit, and (3) includ[ing] a sealed
`connection between the mask chassis/collar structure and Berthon-Jones’s
`cushion/frame sub-assembly,” is based on hindsight. PO Resp. 19. Key to
`Patent Owner’s argument is its contention that a POSITA “would have
`understood that Petitioner’s proposed modifications to the ‘Tenth
`Embodiment’ of Berthon-Jones would directly conflict with several critical
`structures that allow Berthon-Jones’s mask assembly to provide Berthon-
`Jones’s stated purpose for a low-leak mask with enhanced/tailored sealing
`and fit at selected locations on the patient’s face.” Id. at 20–21 (citing Ex.
`1002 ¶¶ 11, 182, 185–186; Ex. 2003 ¶¶ 44–49).
`We recognize the impropriety of basing a conclusion of obviousness
`upon facts gleaned only through hindsight. Nonetheless,
`[a]ny judgment on obviousness is in a sense necessarily a
`reconstruction based upon hindsight reasoning, but so long as it
`takes into account only knowledge which was within the level of
`ordinary skill at the time the claimed invention was made and
`does not include knowledge gleaned only from applicant’s
`disclosure, such a reconstruction is proper.
`In re McLaughlin, 443 F.2d 1392, 1395 (CCPA 1971); see also KSR, 550
`U.S. at 421 (“A factfinder should be aware, of course, of the distortion
`caused by hindsight bias and must be cautious of arguments reliant upon ex
`post reasoning.”). For the reasons discussed below, we do not find that
`Petitioner’s proposed modification to Berthon-Jones using Barnett is based
`impermissibly on hindsight.
`Whether Petitioner’s Proposed Modification Deviates from the
`Intended Purpose and Principle of Operation of Berthon-Jones
`Patent Owner first argues that the proposed modification, i.e.,
`incorporating Barnett’s rigid collar in Berthon-Jones’s mask chassis, is
`unavailing because operation of Berthon-Jones’s adjustment wheels would
`
`
`
`21
`
`
`
`IPR2017-00632
`Patent 8,944,061 B2
`compromise the air-tight seal between the mask and the user, thus rendering
`the resulting mask inoperable for its intended purpose. Id. at 22–29.
`Referring to the specific embodiment in Berthon-Jones that Petitioner relies
`on as “the Tenth Embodiment,” Patent Owner argues that the intended
`purpose of this embodiment “is to provide adjustment wheels that cause its
`cushion/secondary frame to move or deform relative to its mask chassis so
`as to provide small adjus